Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Israel biotech seeks investment

This article was originally published in Clinica

Executive Summary

If $3-4 billion of public and private funds were invested in the Israeli biotechnology sector, sales would be boosted to somewhere in the region of $4 billion within 5-7 years. This is the view put forward by Professor Haim Aviv at a meeting of the board of governors of the Israel-US Binationational and Industrial Research Foundation (BIRD). He said that currently Israel's 160 biotech companies make aggregate sales in the region of $800 million, but that the sector had enjoyed phenomenal growth over the past decade. Further growth was, however, being hampered by lack of financial resources and managerial skill, Professor Aviv said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel